Table of Contents Table of Contents
Previous Page  595 / 1152 Next Page
Information
Show Menu
Previous Page 595 / 1152 Next Page
Page Background

Söhn M, Weinmann M, Alber M. Intensity‐modulated radiotherapy optimization in a quasi‐

periodically deforming patient model. Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):906‐14. 

Hysing LB, Söhn M, Muren LP, Alber M. A coverage probability based method to estimate 

patient‐specific small bowel planning volumes for use in radiotherapy. Radiother Oncol. 

2011 Sep;100(3):407‐11.  

Alber M, Thorwarth D. Multi‐modality functional image guided dose escalation in the 

presence of uncertainties. Radiother Oncol. 2014 Jun;111(3):354‐9.  

Kraan AC, van de Water S, Teguh DN, Al‐Mamgani A, Madden T, Kooy HM, Heijmen BJ, 

Hoogeman MS. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of 

anatomical, range, and setup errors. Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):888‐96.  

Lindegaard JC, Assenholt M, Ramlov A, Fokdal LU, Alber M, Tanderup K. Early clinical 

outcome of coverage probability based treatment planning for simultaneous integrated 

boost of nodes in locally advanced cervical cancer. Acta Oncol. 2017 Aug 29:1‐8. 

Cao W, Lim GJ, Lee A, Li Y, Liu W, Ronald Zhu X, Zhang X. Uncertainty incorporated beam 

angle optimization for IMPT treatment planning. Med Phys. 2012 Aug;39(8):5248‐56. 

Jagt T, Breedveld S, van de Water S, Heijmen B, Hoogeman M. Near real‐time automated 

dose restoration in IMPT to compensate for daily tissue density variations in prostate 

cancer. Phys Med Biol. 2017 Jun 7;62(11):4254‐4272. 

van de Water S, van Dam I, Schaart DR, Al‐Mamgani A, Heijmen BJ, Hoogeman MS. The price 

of robustness; impact of worst‐case optimization on organ‐at‐risk dose and complication 

probability in intensity‐modulated proton therapy for oropharyngeal cancer patients. 

Radiother Oncol. 2016 Jul;120(1):56‐62. 

van der Voort S, van de Water S, Perkó Z, Heijmen B, Lathouwers D, Hoogeman M. 

Robustness Recipes for Minimax Robust Optimization in Intensity Modulated Proton 

Therapy for Oropharyngeal Cancer Patients. Int J Radiat Oncol Biol Phys. 2016 May 

1;95(1):163‐70.